Department of Dermatology, Yale School of Medicine, New Haven, CT, USA
Department of Dermatology, Yale School of Medicine, New Haven, CT, USA
Department of Dermatology, Yale School of Medicine, New Haven, CT, USA
Frank H Netter School of Medicine, Quinnipiac University, North Haven, CT, USA
Department of Dermatology, Yale School of Medicine, New Haven, CT, USA
Department of Dermatology, Yale School of Medicine, New Haven, CT, USA
Department of Dermatology, Yale School of Medicine, New Haven, CT, USA
Department of Pathology, Yale School of Medicine, New Haven, CT, USA
Correspondence: William Damsky. Email: [email protected]
M.J.M and M.H.J. contributed equally and should be considered co-first authors.
Conflicts of interest: J.M.C. serves on a data and safety monitoring board for Advarra and has served as a consultant for Novartis and Takeda. C.A.N. has received research grants from Boehringer Ingelheim and participated in an advisory board for work related to pustular psoriasis and palmoplantar pustulosis. W.D. is a consultant for Eli Lilly, Incyte, Pfizer, Priovant Therapeutics and TWi Biotechnology; he has research funding from AbbVie Pfizer and Advanced Cell Diagnostics/Bio-Techne; and he receives licensing fees from EMD/MilliporeSigma, all outside of the submitted work. M.J.M., M.H.J. and O.R. declare no conflicts of interest.
Received September 05, 2024
Received in revised form November 23, 2024
Accepted December 29, 2024
Revised February 07, 2025
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)
